Pomanda estimates the enterprise value of OXFORD MEDTECH CONSULTING LIMITED at £41k based on a Turnover of £92.9k and 0.44x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of OXFORD MEDTECH CONSULTING LIMITED at £0 based on an EBITDA of £-21k and a 3.02x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of OXFORD MEDTECH CONSULTING LIMITED at £78.7k based on Net Assets of £35.1k and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Oxford Medtech Consulting LimitedOverview
Oxford Medtech Consulting Limited is a live company located in witney, OX29 8PP with a Companies House number of 10832924. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in June 2017, it's largest shareholder is
simon hubbert
with a 100% stake. Oxford Medtech Consulting Limited is a young,
micro sized company, Pomanda has estimated its turnover at
£92.9k with
declining
growth in recent years.
Pomanda's financial health check has awarded Oxford Medtech Consulting Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs
Health Rating1.5out of 5
1 Strong
1 Regular
8 Weak
Size
annual sales of £92.9k, make it smaller than the average company (£1.7m)
£92.9k - Oxford Medtech Consulting Limited
£1.7m - Industry AVG
Growth
3 year (CAGR) sales growth of -29%, show it is growing at a slower rate (8.5%)
-29% - Oxford Medtech Consulting Limited
8.5% - Industry AVG
Production
with a gross margin of 24%, this company has a higher cost of product (46%)
24% - Oxford Medtech Consulting Limited
46% - Industry AVG
Profitability
an operating margin of -22.6% make it less profitable than the average company (5.5%)
-22.6% - Oxford Medtech Consulting Limited
5.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (17)
1 - Oxford Medtech Consulting Limited
17 - Industry AVG
Pay Structure
on an average salary of £48.4k, the company has an equivalent pay structure (£48.4k)
£48.4k - Oxford Medtech Consulting Limited
£48.4k - Industry AVG
Efficiency
resulting in sales per employee of £92.9k, this is less efficient (£112.1k)
£92.9k - Oxford Medtech Consulting Limited
£112.1k - Industry AVG
Debtor Days
it gets paid by customers after 138 days, this is later than average (53 days)
138 days - Oxford Medtech Consulting Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (32 days)
0 days - Oxford Medtech Consulting Limited
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Oxford Medtech Consulting Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Oxford Medtech Consulting Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.3%, this is a lower level of debt than the average (51.5%)
0.3% - Oxford Medtech Consulting Limited
51.5% - Industry AVG
OXFORD MEDTECH CONSULTING LIMITED financials
EXPORT
Oxford Medtech Consulting Limited's latest turnover from March 2024 is estimated at £92.9 thousand and the company has net assets of £35.1 thousand. According to their latest financial statements, we estimate that Oxford Medtech Consulting Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Turnover
92,944
189,906
310,458
262,432
174,098
218,323
133,345
Other Income Or Grants
Cost Of Sales
70,599
144,834
240,016
202,073
128,551
161,928
98,551
Gross Profit
22,345
45,072
70,442
60,359
45,547
56,396
34,794
Admin Expenses
43,373
109,817
21,259
14,647
54,970
29,881
-4,705
Operating Profit
-21,028
-64,745
49,183
45,712
-9,423
26,515
39,499
Interest Payable
Interest Receivable
Pre-Tax Profit
-21,028
-64,745
49,183
45,712
-9,423
26,515
39,499
Tax
-9,345
-8,685
-5,038
-7,505
Profit After Tax
-21,028
-64,745
39,838
37,027
-9,423
21,477
31,994
Dividends Paid
Retained Profit
-21,028
-64,745
39,838
37,027
-9,423
21,477
31,994
Employee Costs
48,435
47,401
44,840
42,387
42,259
85,789
41,813
Number Of Employees
1
1
1
1
1
2
1
EBITDA*
-21,028
-64,745
49,183
45,712
-9,423
26,515
39,499
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Tangible Assets
4,347
4,726
3,404
2,858
2,120
2,827
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
4,347
4,726
3,404
2,858
2,120
2,827
Stock & work in progress
Trade Debtors
35,248
87,446
159,349
123,222
60,055
77,034
47,086
Group Debtors
Misc Debtors
Cash
misc current assets
total current assets
35,248
87,446
159,349
123,222
60,055
77,034
47,086
total assets
35,248
91,793
164,075
126,626
62,913
79,154
49,913
Bank overdraft
Bank loan
Trade Creditors
108
34,515
42,037
44,431
17,725
24,208
14,019
Group/Directors Accounts
355
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
108
34,515
42,037
44,431
17,725
24,563
14,019
loans
hp & lease commitments
Accruals and Deferred Income
1,110
1,125
1,120
1,140
1,120
3,900
other liabilities
provisions
total long term liabilities
1,110
1,125
1,120
1,140
1,120
3,900
total liabilities
108
35,625
43,162
45,551
18,865
25,683
17,919
net assets
35,140
56,168
120,913
81,075
44,048
53,471
31,994
total shareholders funds
35,140
56,168
120,913
81,075
44,048
53,471
31,994
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Operating Activities
Operating Profit
-21,028
-64,745
49,183
45,712
-9,423
26,515
39,499
Depreciation
Amortisation
Tax
-9,345
-8,685
-5,038
-7,505
Stock
Debtors
-52,198
-71,903
36,127
63,167
-16,979
29,948
47,086
Creditors
-34,407
-7,522
-2,394
26,706
-6,483
10,189
14,019
Accruals and Deferred Income
-1,110
-15
5
-20
20
-2,780
3,900
Deferred Taxes & Provisions
Cash flow from operations
-4,347
-379
1,322
546
1,093
-1,062
2,827
Investing Activities
capital expenditure
4,347
379
-1,322
-546
-738
707
-2,827
Change in Investments
cash flow from investments
4,347
379
-1,322
-546
-738
707
-2,827
Financing Activities
Bank loans
Group/Directors Accounts
-355
355
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
interest
cash flow from financing
-355
355
cash and cash equivalents
cash
overdraft
change in cash
oxford medtech consulting limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for oxford medtech consulting limited. Get real-time insights into oxford medtech consulting limited's credit score, group structure and payment trends.
Perform a competitor analysis for oxford medtech consulting limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in OX29 area or any other competitors across 12 key performance metrics.
oxford medtech consulting limited Ownership
OXFORD MEDTECH CONSULTING LIMITED group structure
Oxford Medtech Consulting Limited has no subsidiary companies.
Ultimate parent company
OXFORD MEDTECH CONSULTING LIMITED
10832924
OXFORD MEDTECH CONSULTING LIMITED Shareholders
The sole shareholder of Oxford Medtech Consulting Limited is Simon Hubbert.
simon hubbert
100%
oxford medtech consulting limited directors
Oxford Medtech Consulting Limited currently has 1 director, Mr Simon Hubbert serving since Jun 2017.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to oxford medtech consulting limited.
oxford medtech consulting limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for OXFORD MEDTECH CONSULTING LIMITED. This can take several minutes, an email will notify you when this has completed.
oxford medtech consulting limitedCompanies House Filings - See Documents
